Charmacy Pharmaceutical Co., Ltd.

HK$5.49As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2289Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (0.40%)
Div yield 6.38%
ROE 7.86%
Medical Distribution
Beta (5Y) (1.03)
PE TTM 10.91
TSR TTM 7.45%
Mkt cap HK$592.9M
ROIC 5.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.39
(1.83%)
(4.09%)
Hold 8|3|12|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.08
9.12%
2.51%
3.27%
14.43%
Revenue¥M
69.98
71.17
72.46
70.92
5.11%
7.20%
10.09%
5.49%
Peers (US$75.63M)
Cap (US$)
PE
25.51M
—
Capital
TTM
5Y
10Y
Leveragex
1.162
0.215
0.197
EBIT/Intx
1.840
0.472
0.360
Own earn%
(0.78)
74.00
75.18
Sh yield%
47.63
41.01
37.10
Owners
Insiders/Inst%
1.11
40.63
Short interest%
0.71
SBC / revenue%
2.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–21
$1 testx
—
Incr. ROIC%
13